Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Medical devices to be...

    Medical devices to be regulated as drugs for quality control, price monitoring: Government

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-04-01T11:44:07+05:30  |  Updated On 1 April 2020 9:01 AM GMT
    Medical devices to be regulated as drugs for quality control, price monitoring: Government

    Delhi: All medical devices shall be regulated by the government as drugs for quality control and price monitoring from April 1, 2020, the Ministry of Chemicals and Fertilizers said in a statement on Tuesday. The National Pharmaceutical Pricing Authority (NPPA) in its a notification on Tuesday stated that all medical devices shall be governed under the provisions of the Drugs (Prices Control) Order, 2013, with effect from Wednesday, it added.

    "Therefore, the maximum retail prices (MRPs) of all the medical devices would be monitored by the government under the provisions of Para 20(1) of the DPCO, 2013, to ensure that no manufacturer/importer increases the MRP of a drug more than 10 percent of MRP during preceding 12 months and where the increase is beyond 10 percent of the maximum retail price, it shall reduce the same to the level of ten percent of the maximum retail price for next twelve months," the statement said.

    The manufacturer and importer shall also be liable to deposit the overcharged amount along with interest thereon from the date of the increase in price in addition to the penalty, it added.

    In another statement, the government also said that in compliance with the provisions of Drugs (Price Control) Order, 2013, the NPPA has increased the ceiling price of 883 scheduled formulations.

    The increase in ceiling price is based on the Wholesale Price Index.

    The revision in the ceiling price of formulations includes the revision of the ceiling price of cardiac stents also. The revised prices will be applicable from Wednesday.

    Read also: Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    nppa coronavirus covid-19 national-pharmaceutical-pricing-authority 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X